Concord falls as US loses enthusiasm for China IPOs
Concord Medical Services, which runs cancer screening and treatment centres in China, tumbled 13.6% on its first day of trading in New York on Friday in the latest sign that US enthusiasm for Chinese IPOs is waning as investors close their books for the year.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts